SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities
SEC Accession No. 0001144204-12-014965
Filing Date
2012-03-14
Accepted
2012-03-14 17:37:12
Documents
1
Period of Report
2012-03-12
Filing Date Changed
2012-03-14

Document Format Files

Seq Description Document Type Size
1 form449365_20120314053655-.html 4  
1 form449365_20120314053655-.xml 4 16775
  Complete submission text file 0001144204-12-014965.txt   19213
Mailing Address BAKER BROTHERS ADVISORS 667 MADISON AVENUE, 21ST FLOOR NEW YORK NY 10065
Business Address
BAKER JULIAN (Reporting) CIK: 0001087939 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35119 | Film No.: 12691300

Mailing Address BAKER BROTHERS ADVISORS 667 MADISON AVENUE, 21ST FLOOR NEW YORK NY 10065
Business Address
BAKER FELIX (Reporting) CIK: 0001087940 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35119 | Film No.: 12691301

Mailing Address 5001 SOUTH MIAMI BOULEVARD SUITE 300 DURHAM NC 27703
Business Address 5001 SOUTH MIAMI BOULEVARD SUITE 300 DURHAM NC 27703 919 474 0020
TRANZYME INC (Issuer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 667 MADISON AVENUE 21ST FLOOR NEW YORK NY 10065
Business Address 667 MADISON AVENUE 21ST FLOOR NEW YORK NY 10065 212-339-5600
Baker Brothers Life Sciences Capital (GP), LLC (Reporting) CIK: 0001307729 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35119 | Film No.: 12691302